Navigating Drug Testing Billing: Common Claim Errors and How to Prevent Them

In behavioral health settings, especially those addressing Substance Use Disorders (SUD), drug testing serves as a valuable clinical tool. It can help support treatment planning, monitor progress, and promote accountability. For providers, accurately billing for these essential services is critical to supporting revenue cycle stability and continued service provision.

However, drug testing billing is often complex, with specific requirements varying by payer, service type, and the clinical context in which the test is performed. Missteps in documentation or coding can lead to claim denials, payment delays, and increased administrative burden. Understanding the landscape of potential errors is the first step toward prevention.

Perhaps the most frequent reason for drug testing claim denials stems from insufficient documentation of medical necessity. Payers, including New Mexico Medicaid MCOs, require clear evidence that the drug test was clinically indicated and directly supports the patient's treatment plan. This means a simple standing order or routine testing without specific justification may not be sufficient.

Documentation should articulate why the test was performed, how the results will inform treatment decisions, and its relevance to the patient's current behavioral health presentation or SUD recovery goals. Examples of acceptable indications might include monitoring compliance with a treatment contract, investigating suspected relapse, or assessing for concurrent substance use affecting mental health treatment. The record should reflect an individualized clinical rationale for each test ordered.

Selecting the correct CPT or HCPCS code for drug testing services is essential. The AMA CPT code set includes various codes for qualitative (screening) and quantitative (confirmatory) drug tests, differentiating between presumptive and definitive methods. Misapplication of these codes, such as billing a definitive test when only a presumptive screening was performed, will result in denials.

Furthermore, specific modifiers are often required to indicate the circumstances under which the test was performed, such as multiple services on the same day or a professional component. For instance, some payers may require a modifier to distinguish between lab services performed in-house versus those sent to an outside lab, or to indicate a distinct procedural service. Incorrect or missing modifiers are a common source of claim rejections. It is crucial to verify the current CPT code descriptors and modifier usage guidelines with the specific payer.

New Mexico Billing supports workflows involving these codes and modifiers, helping providers ensure their claims accurately reflect the services delivered.

While not all drug tests require prior authorization, many payers, including various New Mexico Medicaid MCOs, may require it for certain types of drug testing, particularly for quantitative or more extensive panels. Failure to obtain authorization before rendering services is a common cause of denials where authorization is required.

Similarly, some MCO plans may require a referral from a primary care provider or another specialist before drug testing services can be billed. Providers must proactively verify these requirements for each patient's specific plan and service date. This information is typically available through the MCO's provider portal or by contacting their provider services line.

Payers only cover drug tests that are considered medically necessary and are established, non-experimental methods. Billing for tests that are deemed experimental, investigational, or not within the scope of covered benefits for behavioral health can lead to denials. It is important for providers to stay informed about what specific drug testing methodologies and panels are covered by the MCOs and New Mexico Medicaid.

This also extends to the frequency of testing. Some payers have limitations on how often certain drug tests can be performed within a given timeframe without additional clinical justification. Exceeding these frequency limits without strong documentation of medical necessity for the additional tests may result in denials.

A foundational step for any billing process is verifying patient eligibility and benefits. For drug testing, this includes confirming active coverage on the date of service, understanding any cost-sharing responsibilities (though less common in NM Medicaid behavioral health for these services), and identifying any specific drug testing benefit carve-outs or limitations.

Failure to verify eligibility can lead to claims being denied because the patient was not covered by the MCO on the service date, or the specific service is not a covered benefit under their plan. This step should ideally be performed at every visit or at minimum, prior to any new course of treatment involving drug testing.

Preventing drug testing claim errors requires a systematic approach. Implement clear internal protocols for ordering, documenting, and coding drug tests. Ensure your clinical and billing staff are trained on the latest payer guidelines and CPT coding updates. Regular audits of documentation and claims can identify recurring issues before they impact a significant portion of your revenue cycle. Leveraging technology, such as an EHR or billing system with robust claim scrubbing capabilities, can also flag potential errors before submission.

New Mexico Billing offers support for behavioral health providers in navigating these complex billing requirements. Our team is familiar with the intricacies of New Mexico Medicaid workflows and MCO credentialing, providing operational guidance to help minimize claim errors and optimize your revenue cycle processes, including those involving drug testing.

Navigating the complexities of drug testing billing in behavioral health can be challenging, but with the right processes and support, common errors can be significantly reduced. Proactive verification, meticulous documentation, and accurate coding are your strongest defenses against denials.

If you're seeking to streamline your drug testing billing and minimize claim errors, consider a review of your current processes. Enhancing your team's understanding of payer expectations and implementing robust billing workflows can lead to greater efficiency and improved revenue cycle health. New Mexico Billing is familiar with optimizing behavioral health billing for New Mexico providers, supporting workflows for services like drug testing. We encourage you to explore how specialized support can benefit your practice.